Issue navigation
Volume 27, Issue Supplement_1, February 2025
Place 2024 Platform of Laboratories for Advances in Cardiac Experience
Focus on Cardiovascular Prevention and Ischaemic Cardiopathy
Oral semaglutide: an innovative paradigm in the management of cardiovascular risk in patients with Type 2 diabetes
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i1–i5, https://doi.org/10.1093/eurheartjsupp/suae086
Over 10 years of non-vitamin K antagonist oral anticoagulants: highlights, challenges, and future developments
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i6–i11, https://doi.org/10.1093/eurheartjsupp/suae087
Left atrial appendage occlusion: behind the bleeding risk
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i12–i15, https://doi.org/10.1093/eurheartjsupp/suae094
Cardiovascular risk assessment in daily clinical practice: when and how to use a risk score
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i16–i21, https://doi.org/10.1093/eurheartjsupp/suae100
The era of interventional imaging has arrived: what role for computed tomography and magnetic resonance?
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i22–i26, https://doi.org/10.1093/eurheartjsupp/suae112
The role of functional assessment in the management of ischaemic heart disease
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i27–i30, https://doi.org/10.1093/eurheartjsupp/suae121
Focus on Cardiomyopathy, Channellopathy and Sudden Death
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i31–i35, https://doi.org/10.1093/eurheartjsupp/suae096
Risk stratification in arrhythmogenic cardiomyopathy: scoring or personalized medicine?
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i36–i39, https://doi.org/10.1093/eurheartjsupp/suae098
From thick walls to clear answers: approaches to diagnosing hypertrophic cardiomyopathy and its mimics
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i40–i46, https://doi.org/10.1093/eurheartjsupp/suae099
Managing long QT syndrome patients, cooking, and common sense
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i47–i50, https://doi.org/10.1093/eurheartjsupp/suae085
Cardiac involvement in Fabry disease: Recent advances, unresolved issues, and unmet needs
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i51–i55, https://doi.org/10.1093/eurheartjsupp/suae104
Acute myocarditis: 2024 state of the art
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i56–i60, https://doi.org/10.1093/eurheartjsupp/suae105
Myocarditis diagnosis: From light microscope to molecular analysis and cardiac magnetic resonance
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i61–i66, https://doi.org/10.1093/eurheartjsupp/suae106
The contemporary role of genetics in cardiovascular medicine: from phenotypes to precision diagnoses
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i67–i72, https://doi.org/10.1093/eurheartjsupp/suae107
The ‘Padua classification’ of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i73–i82, https://doi.org/10.1093/eurheartjsupp/suae108
The diagnostic value of electrocardiogram in the left variants of desmosomal arrhythmogenic cardiomyopathy
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i83–i87, https://doi.org/10.1093/eurheartjsupp/suae110
Cardiac amyloidosis: Innovations in diagnosis and treatment
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i88–i97, https://doi.org/10.1093/eurheartjsupp/suae111
Genetics in arrhythmogenic cardiomyopathies: where are we now and where are we heading to?
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i98–i102, https://doi.org/10.1093/eurheartjsupp/suae114
Heart Failure
Periodic breathing during exercise in heart failure: beyond the classic risk factors
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i103–i108, https://doi.org/10.1093/eurheartjsupp/suae091
The right ventricle: the co-star in the complex history of heart failure
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i109–i114, https://doi.org/10.1093/eurheartjsupp/suae092
Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i115–i121, https://doi.org/10.1093/eurheartjsupp/suae095
Implantable cardiac monitor in heart failure: just a toy or a useful tool?
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i122–i125, https://doi.org/10.1093/eurheartjsupp/suae097
Remote monitoring and heart failure
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i126–i131, https://doi.org/10.1093/eurheartjsupp/suae116
The clinical and pharmacoeconomic impact of established and novel heart failure therapies
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i132–i136, https://doi.org/10.1093/eurheartjsupp/suae118
SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i137–i140, https://doi.org/10.1093/eurheartjsupp/suae117
Chronic Cardiac Failure: The Revolution
Pacing of the specialized His Purkinje conduction system: ‘HOW and FOR WHOM’
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i141–i148, https://doi.org/10.1093/eurheartjsupp/suae113
Can we slow down the decline in renal function?
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i149–i153, https://doi.org/10.1093/eurheartjsupp/suae123
Focus on Arrhtyhmias and Syncope
The role of antiarrhythmic drugs and stellate ganglion block in the acute management of electrical storm
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i154–i161, https://doi.org/10.1093/eurheartjsupp/suae084
Subclinical atrial fibrillation/atrial high-rate episodes: what significance and decision-making?
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i162–i166, https://doi.org/10.1093/eurheartjsupp/suae088
Pulsed field ablation in atrial fibrillation ablation: where are we and where are we going?
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i167–i170, https://doi.org/10.1093/eurheartjsupp/suae103
Endocardial gaglionated plexi ablation in different vagally-mediated clinical settings: From cardioneuroablation to cardio-neuromodulation
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i171–i176, https://doi.org/10.1093/eurheartjsupp/suae109
Abstracts
Clinical heterogeneity in a family with pathogenic variant in the KCNQ1 gene: Dilated cardiomyopathy and Long QT Syndrome
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Page i177, https://doi.org/10.1093/eurheartjsupp/suae124.001
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure Results from the SOLVE-CRT Randomised Sub-study
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i177–i178, https://doi.org/10.1093/eurheartjsupp/suae124.002
Accessory Fascicolo-Ventricular Pathway in Hypertrophic Phenotype Cardiomyopathy Suspected for Prkag2 Mutation: Diagnostic Role of Myocardial Biopsy
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Page i178, https://doi.org/10.1093/eurheartjsupp/suae124.003
Correction
Correction to: Genetics in arrhythmogenic cardiomyopathies: where are we now and where are we heading to?
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Page i102, https://doi.org/10.1093/eurheartjsupp/suaf078
